Newborn Screening Test for Spinal Muscular Atrophy

To facilitate collaborative development of a newborn bloodspot screening test to detect the genetic lesions that cause spinal muscular atrophy. The test will be designed to use in public health newborn screening laboratories.
Funding Partners:
  • Biogen MA Inc.
Program Partners:
  • CDC's Division of Laboratory Sciences
Program Location:
  • United States of America